Rene Daniel

Title: Innovations in Retroviral Treatment by Inventor Rene Daniel

Introduction

Rene Daniel is an accomplished inventor based in Ambler, PA (US). He has made significant contributions to the field of retroviral infection treatment through his innovative research and patent development. His work focuses on identifying cellular targets that can be utilized in the development of anti-retroviral drugs.

Latest Patents

Rene Daniel holds a patent for "Cellular targets for treatment of retroviral infection." This patent discloses cellular targets comprising ATR kinase and its relevant substrates. The identification of ATR kinase as essential for the final step of retroviral DNA integration is a key aspect of this invention. The patent also includes assays for identifying modulators of retroviral integration via the ATR kinase pathway, as well as pharmaceutical preparations and methods for treating retroviral infections.

Career Highlights

Rene Daniel is affiliated with the Fox Chase Cancer Center, where he conducts his research. His work has been instrumental in advancing the understanding of retroviral infections and developing potential treatments. His dedication to scientific innovation has positioned him as a notable figure in the field.

Collaborations

Rene collaborates with esteemed colleagues, including Anna Marie Skalka and Gary D. Kao. Their combined expertise enhances the research efforts at the Fox Chase Cancer Center, contributing to the advancement of knowledge in retroviral treatment.

Conclusion

Rene Daniel's innovative work in the field of retroviral infection treatment exemplifies the impact of scientific research on public health. His patent and collaborations highlight the importance of targeted therapies in combating viral infections.